HDAC9 and rheumatoid arthritis: Nonselective HDAC inhibitor trichostatin A (TSA) shared multiple molecular mechanism in suppressing inflammation and may represent a new principle in the treatment of RA (Chung et al., 2003; Gillespie et al., 2012; Grabiec et al., 2012).